GLP-2 — glucagon-like peptide-2 — has emerged as one of the most scientifically compelling peptides in gastrointestinal biology research. As a 33-amino acid proglucagon-derived peptide secreted by enteroendocrine L-cells of the intestinal epithelium, GLP-2 has attracted significant laboratory interest for its highly specific effects on intestinal mucosal growth, barrier integrity, and nutrient absorption signaling. Researchers investigating gut physiology, epithelial regeneration, and metabolic crosstalk have increasingly focused on GLP-2 and its stabilized analogs as tools for probing these mechanisms at the preclinical level.
This article serves as a foundational entry point into GLP-2 research for scientists building their understanding of this peptide system. For a deeper dive into the full GLP-2 and GLP-2T research landscape, be sure to read the complete GLP-2 & GLP-2T research guide, which covers the teduglutide analog, receptor pharmacology, and laboratory protocol considerations in comprehensive detail.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied.
GLP-2 (T) 10MG — Research-Grade Reference Material GLP-2 (T) 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
GLP-3 (R) 10MG
$110.00$82.50 with 1st order
GLP-3 (R) 30MG
$190.00$142.50 with 1st order
BPC-157 - 10MG
$55.00$41.25 with 1st order
Frequently Asked Questions
What is GLP-2 and where is it produced in the body?
GLP-2 (glucagon-like peptide-2) is a 33-amino acid peptide derived from the proglucagon gene, primarily secreted by L-cells located in the distal small intestine and colon in response to nutrient ingestion. Research models have consistently identified it as a gut-specific trophic signal with highly localized receptor expression.
What receptor does GLP-2 act on?
GLP-2 acts on a specific G-protein coupled receptor known as GLP-2R, which research has found to be expressed predominantly in enteric neurons, enteroendocrine cells, subepithelial myofibroblasts, and intestinal smooth muscle. This restricted receptor distribution is a major reason for GLP-2’s apparent gut-specificity in preclinical models.
What has GLP-2 research shown about intestinal structure?
Studies in animal models have investigated GLP-2’s role in promoting intestinal epithelial proliferation and inhibiting apoptosis. Preclinical data suggest GLP-2 administration is associated with increased villus height and crypt depth in the small intestine, potentially enhancing surface area available for nutrient absorption — effects that have made it a subject of significant gut biology research.
What is the difference between GLP-2 and teduglutide (GLP-2T)?
Native GLP-2 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), giving it a very short half-life of only a few minutes in circulation. GLP-2T (teduglutide) is a research analog where an alanine-to-glycine substitution at position 2 confers resistance to DPP-4 cleavage, significantly extending its activity window in preclinical experimental models.
How does GLP-2 relate to intestinal barrier function research?
A significant area of GLP-2 research involves its effects on tight junction proteins and intestinal permeability. Preclinical studies have reported that GLP-2 signaling appears to upregulate claudin and occludin expression in gut epithelial models, suggesting a role in barrier maintenance that researchers continue to investigate in controlled laboratory settings.
Is GLP-2 related to GLP-1 research?
Both GLP-1 and GLP-2 are co-secreted from proglucagon-expressing L-cells, but they act on different receptors and have distinct biological research profiles. While GLP-1 research has focused heavily on metabolic and glycemic signaling, GLP-2 studies have remained more focused on intestinal trophic and barrier functions in preclinical models.
Where can I find the most comprehensive GLP-2 research guide?
The GLP-2 & GLP-2T complete research guide on SourcePeptides covers receptor pharmacology, analog design, laboratory reconstitution protocols, and the full peer-reviewed literature base in one comprehensive resource.
What form is GLP-2 available in for laboratory research?
For laboratory use, GLP-2 peptides are typically available in lyophilized powder form, which offers stability advantages during storage and shipping. Researchers generally reconstitute peptides prior to in vitro or in vivo experimental use using appropriate sterile solvents. Understanding what lyophilized peptide form means for research is an important foundation before beginning protocols.
The Biological Origins of GLP-2: Proglucagon Processing and L-Cell Secretion
To understand GLP-2 at a mechanistic level, researchers begin with proglucagon — a precursor protein encoded by the GCG gene that undergoes tissue-specific post-translational processing. In pancreatic alpha cells, proglucagon is cleaved to yield glucagon. In intestinal L-cells and brainstem neurons, however, a different set of prohormone convertases (primarily PC1/3) process proglucagon into a suite of biologically active fragments including GLP-1, GLP-2, glicentin, and oxyntomodulin.
GLP-2 (T) 10MG — Research-Grade Reference Material GLP-2 (T) 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
GLP-3 (R) 10MG
$110.00$82.50 with 1st order
GLP-3 (R) 30MG
$190.00$142.50 with 1st order
BPC-157 - 10MG
$55.00$41.25 with 1st order
GLP-2 is released from these L-cells in a nutrient-sensitive manner, with fat and carbohydrate intake being the primary stimulatory signals identified in research models. Its co-secretion with GLP-1 has made comparative studies between the two peptides scientifically informative, though their divergent receptor targets and downstream biology have kept GLP-2 research on a largely independent track. The GLP-2 mechanisms and biology laboratory guide explores this proglucagon processing pathway and its laboratory implications in significantly greater depth.
DPP-4 and the Half-Life Problem
One of the defining challenges in native GLP-2 research is its extremely short circulating half-life — estimated at approximately 7 minutes in vivo due to rapid N-terminal cleavage by the enzyme dipeptidyl peptidase-4 (DPP-4). This rapid degradation has important implications for experimental design: researchers using native GLP-2 in animal models must account for this pharmacokinetic limitation when designing dosing protocols and interpreting results.
The development of DPP-4-resistant GLP-2 analogs — most notably the teduglutide variant (GLP-2T) — emerged directly from this research challenge. By substituting glycine for alanine at position 2 of the peptide sequence, researchers created a molecule with a substantially extended half-life that enables more practical preclinical experimental protocols. For researchers interested in the comparative biology of native GLP-2 versus its stabilized analogs, the complete GLP-2 & GLP-2T guide provides an essential reference.
GLP-2 Receptor Signaling: What Research Has Mapped So Far
The GLP-2 receptor (GLP-2R) is a class B G-protein coupled receptor (GPCR) that shares structural homology with the GLP-1 receptor, glucagon receptor, and other members of the secretin family. Research has established that GLP-2R activation primarily couples to Gs proteins, leading to adenylate cyclase activation and elevated intracellular cAMP — a canonical signaling pathway shared with many gut hormone receptors.
What has made GLP-2R particularly interesting to researchers is its expression pattern. Unlike the GLP-1 receptor, which is found broadly across multiple organ systems, GLP-2R expression appears highly concentrated within the gastrointestinal tract. Studies have localized GLP-2R to enteric neurons of the submucosal and myenteric plexus, intestinal subepithelial myofibroblasts (ISEMFs), smooth muscle cells, and certain enteroendocrine cell populations. Notably, the receptor appears to be largely absent from intestinal epithelial cells themselves — a finding that has driven research into the indirect signaling mechanisms through which GLP-2 exerts its trophic effects on the epithelium.
Indirect Mechanisms: IGF-1, EGF, and Enteric Neuronal Signaling
Because GLP-2R is not expressed on enterocytes directly, preclinical research has investigated the intermediary signals through which GLP-2 stimulates epithelial growth. Studies have identified insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), and keratinocyte growth factor (KGF) as candidate downstream mediators. Enteric neuron-derived signals have also been studied as potential relay mechanisms. This multi-step signaling cascade represents a sophisticated paracrine network that researchers continue to map with increasing resolution.
GLP-2 (T) 10MG Nasal Spray for research →
Key Research Areas: What Laboratory Studies Have Investigated
Intestinal Mucosal Growth and Villus Architecture
Among the most replicated findings in GLP-2 preclinical research is its apparent ability to promote intestinal mucosal growth. Animal studies have consistently reported increases in small intestinal weight, villus height, and crypt cell proliferation following GLP-2 or GLP-2T administration. These structural changes in intestinal architecture are associated with enhanced absorptive surface area in experimental models — observations that have made GLP-2 a subject of significant interest in gut biology research contexts.
Tight Junction Proteins and Barrier Integrity
A growing body of preclinical research has examined GLP-2’s effects on intestinal barrier function. Studies have reported associations between GLP-2 signaling and upregulation of tight junction proteins including claudin-3, occludin, and ZO-1 in rodent models. These proteins are critical structural components of the paracellular barrier that prevents luminal contents from accessing systemic circulation. The mechanistic relationship between GLP-2’s trophic effects and its apparent barrier-supportive properties remains an active area of investigation.
Motility and Transit Research
Beyond its mucosal effects, GLP-2 research has explored its influence on gastrointestinal motility. Preclinical data suggest that GLP-2 may slow gastric emptying and intestinal transit — effects potentially mediated through its action on enteric neurons rather than smooth muscle directly. These motility findings have been investigated alongside the peptide’s absorptive effects to understand its broader physiological role in nutrient handling.
Inflammatory Pathway Modulation
Several preclinical studies have examined GLP-2 in inflammatory models of the gut, reporting potential anti-inflammatory associations in controlled experimental settings. Research has explored cytokine profiles, neutrophil infiltration markers, and mucosal injury scores in animal models of intestinal inflammation receiving GLP-2 or analog treatment. These findings have added another dimension to the GLP-2 research landscape, though mechanistic pathways in this area remain under active investigation.
GLP-2 (T) 10MG Nasal Spray for laboratory use →
GLP-2 and the Broader Gut-Metabolic Axis
Researchers have increasingly situated GLP-2 within the broader context of gut-metabolic signaling, examining how its intestinal effects connect to systemic metabolic parameters. Studies in animal models have investigated relationships between GLP-2-mediated changes in intestinal surface area and alterations in lipid absorption efficiency, as well as potential secondary effects on body composition and energy homeostasis.
This metabolic research context has placed GLP-2 alongside other gut-derived peptides in multi-axis research programs. For example, its co-secretion with GLP-1 from L-cells has led researchers to examine combined signaling studies, while its relationship to intestinal lipid handling has drawn connections to broader metabolic research areas. Scientists studying compounds like GLP-3 retatrutide research will find the GLP peptide family comparisons particularly relevant to their work.
The intersection of intestinal biology and systemic metabolism represents one of the most productive areas of current GLP-2 research, with studies continuing to refine understanding of how gut trophic signals influence whole-body physiology in preclinical models.
Laboratory Considerations for GLP-2 Research
Peptide Stability and Storage
GLP-2 in lyophilized form offers improved stability compared to solution, but researchers must observe appropriate storage conditions — typically at -20°C or below for long-term preservation. Understanding the role of excipients in peptide formulations is important for maintaining integrity; researchers interested in this area may benefit from reviewing why mannitol and other stabilizers are added to peptide preparations to understand formulation science relevant to their protocols.
Reconstitution and Dosing Protocols
Standard laboratory practice for GLP-2 research involves reconstitution in sterile water or appropriate buffer solutions, with concentration calculations carefully verified against peptide mass documentation. Given native GLP-2’s rapid DPP-4 degradation, researchers working with the native sequence in in vivo models must design administration schedules that account for the short half-life. GLP-2T analogs offer more experimental flexibility in this regard.
Model Selection Considerations
Research using GLP-2 has employed a range of preclinical models including rodent intestinal resection models, inflammatory bowel models, and in vitro intestinal organoid cultures. Each model type has specific advantages and limitations for investigating different aspects of GLP-2 biology. Researchers designing new protocols should carefully consider which experimental system best aligns with their specific research question regarding GLP-2 signaling or intestinal biology.
GLP-2 Nasal Spray research formulations →
GLP-2 in Context: Related Peptide Research Areas
GLP-2 research does not exist in isolation — it connects naturally to several adjacent peptide research domains. Scientists studying gut barrier biology may find productive parallels with BPC-157 and TB-500 research, where similar themes of epithelial repair and tissue integrity signaling have been investigated through different mechanistic pathways. The structural biology of GPCRs connects GLP-2R research to oxytocin receptor studies and other class B receptor systems.
For researchers building a comprehensive understanding of gut-metabolic peptide signaling, the full GLP peptide family — including GLP-1 (semaglutide-type analogs), GLP-2 (teduglutide-type analogs), and GLP-3 receptor targeting research — represents a coherent research area with shared mechanistic themes and divergent tissue-specific biology.
GLP-1 (S) 10MG Nasal Spray for research →
GLP-3 (R) 10MG Nasal Spray for research →
Where These Fit in Your Research Library
Researchers building a GLP peptide research program will find these resources and products most relevant:
- GLP-2 & GLP-2T Complete Research Guide — the primary pillar article for this research cluster
- GLP-2 Mechanisms, Biology & Laboratory Guide 2026 — deep mechanistic companion article
- GLP-2 (T) Peptide Research Guide: Intestinal Biology & Laboratory Applications
Browse the full SourcePeptides research peptide catalog for the complete range of GLP-family and related research compounds.
Summary: What the GLP-2 Research Field Shows in 2026
GLP-2 is a gut-specific peptide with a well-defined receptor system and a consistent preclinical research profile centered on intestinal mucosal growth, barrier integrity, and motility modulation. Its short native half-life has driven the development of stabilized research analogs, and its highly restricted receptor expression pattern has made it a scientifically valuable tool for investigating paracrine intestinal signaling networks.
For researchers entering this field, the most important next step is engaging with the full body of GLP-2 literature. The complete GLP-2 & GLP-2T research guide provides the most comprehensive single-source overview of receptor pharmacology, analog design, key preclinical studies, and laboratory protocol considerations — making it the essential starting point for any serious GLP-2 research program. Alongside that, the GLP-2 mechanisms and biology laboratory guide offers complementary depth on signaling pathways and experimental design considerations for 2026 and beyond.
Sources & Further Reading
- Drucker DJ et al. — “Intestinal epithelial growth and cell survival are regulated by GLP-2” — Endocrinology (1999)
- Munroe DG et al. — “Protease-resistant peptide analogs of glucagon-like peptide 2 with improved biological activity” — Journal of Biological Chemistry (2002)
- Brubaker PL & Drucker DJ — “Glucagon-like peptides regulate the growth and function of the intestinal epithelium” — Peptides (2004)
- PubMed Search — GLP-2 intestinal barrier and tight junction research
- PubMed Search — GLP-2 receptor signaling studies
- GLP-2 & GLP-2T Peptide: The Complete Research Guide COMPLETE GUIDE
- GLP-2 Peptide Research: Mechanisms, Biology & Laboratory Guide 2026
- GLP-2 Peptide Research: A Focused Guide for Scientists Studying Gut Biology in 2026
- GLP2 Peptide: The Essential Research Guide for Scientists in 2026
- GLP2-T Peptide: A Complete Research Guide for Scientists (2026)
- Difference Between GLP-1 and GLP-2: A Researcher’s Guide to Two Divergent Incretin Peptides
